Robinson Chandler Insider Trades & Stock Holdings

Chief Executive Officer · Monopar Therapeutics Inc. · Latest filing Sep 24, 2026

Robinson Chandler, Chief Executive Officer at Monopar Therapeutics Inc. has 1 Form 4 trade on file since Sep 24, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($2.56M), net -$2.56M. Latest filing: disposed of 29.06K shares of $MNPR on Sep 24, 2026 at $88.

Trades on file

1

Open-market bought

$0

Open-market sold

$2.56M

Net open-market

-$2.56M

Latest filing

Sep 24, 2026

All insider trades by Robinson Chandler

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 24, 2026	$MNPR	Sell (Open-market sale) 10b5-1	29.06K	$88	$2.56M			-12.2%			Chief Executive Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Robinson Chandler traded

• $MNPR

Frequently asked questions

Has Robinson Chandler been buying or selling stock?

Robinson Chandler has 0 open-market purchases and 1 open-market sale on file, net -$2.56M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Robinson Chandler's latest insider trade?

disposed of 29.06K shares of $MNPR on Sep 24, 2026 at $88.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.